- Alpha thalassemia
- Anemia
- Autoimmune hemolytic anemia
- Beta thalassemia
- Beta thalassemia intermedia
- Hemochromatosis
- Hemoglobin H disease (HbH)
- Hemolytic anemia
- Hereditary elliptocytosis
- Hereditary hemochromatosis
- Hereditary pyropoikilocytosis
- Hereditary spherocytosis
- High ferritin level
- Iron deficiency anemia
- Low hemoglobin
- Pernicious anemia
- Pure red-cell aplasia (PRCA)
- Sickle cell disease
- Spherocytosis
- Thalassemia
- Transfusional iron overload
- Vitamin B12 deficiency
Elizabeth A. Traxler, MD, PhD
About me
- Assistant Professor of Medicine (Hematology-Oncology)
My education and training
- Medical School: University of Pennsylvania School of Medicine
- Residency: University of Pennsylvania Health System
- Fellowship: University of Pennsylvania Health System
Spoken languages
Insurance accepted
- Aetna Advantra Cares D-SNP
- Aetna Advantra Credit Value
- Aetna Advantra Eagle HMO
- Aetna Advantra Eagle POS
- Aetna Advantra Premier Plus PPO
- Aetna Advantra Value
- Aetna Advantra Value Plus
- Aetna APCN Plus (Multi-Tier)
- Aetna Better Health Kids (CHIP) - DH Only
- Aetna Flexible Five
- Aetna Freedom Core
- Aetna Gold
- Aetna HMO
- Aetna Philly Prime
- Aetna POS
- Aetna PPO APCN
- Aetna Premier
- Aetna Premier Plus
- Aetna Savings Plus
- Aetna Signature Administrators
- Aetna Student Health Plan PPO
- Aetna Upfront Advantage
- First Health HMO
- First Health POS
- First Health PPO
- Meritain - Aramark (Other)
- Meritain - Aramark (Pennsylvania Premier Medical Plan)
- Americhealth Caritas of PA VIP - LGH Only
- Amerihealth Caritas (Transplant patients only)
- Amerihealth Caritas of PA - LGH Only
- Centivo EPO
- Cigna Healthcare EPO
- Cigna Healthcare HMO
- Cigna Healthcare POS
- Cigna Healthcare PPO
- Claim Watcher (Homestead/ INDECs) Open Access
- Clover Health Choice
- Clover Health Choice Value PPO
- Clover Health Classic HMO
- Clover Health Value
Locations
Penn Medicine hospital privileges
- Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
Qualifications and experience
- Hematology, 2024
- Internal Medicine, 2021
- American Society of Hematology, National
Treatments and conditions
Research
Publications
Traxler, EA, Komar, C, Saari, M, Thrasher, M, Qin, K, Khandros, E, Hotan, Q, Abdulmalik, O, Shao, C, Chen, Q, Minn, AJ, Keller, CA, Shi, J, Blobel, GA. Genome-scale CRISPR-Cas12a screen identifies novel fetal hemoglobin regulators. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Sayani, FA, Liu, M, Frimpong, Y, Peslak, SA, Traxler, EA, Cohen, J, Russell, JE, Kwiatkowski, JL. Adults with transfusion-dependent thalassemia have variable clinical profiles depending on where they receive care: thalassemia treatment center vs community. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Cheng, A, Traxler, EA, Peslak, SA, Cohen, J, Russell, JE, Sayani, FA. Patients with non-transfusion-dependent thalassemia may evolve to transfusion-dependent thalassemia in adulthood. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Peslak, SA, Abbas, T, Khandros, E, Traxler, EA, Abdulmalik, O, Giardine, B, Keller, CA, Hardison, R, Shi, J, Blobel, GA. Protein phosphatase 6 complex: novel regulator of fetal hemoglobin and potential therapeutic target in sickle cell disease. , The American Society of Hematology Annual Meeting, San Diego, CA.: 2023
Elizabeth A Traxler, Elizabeth O Hexner. Running interferon interference in treating PV/ET: meeting unmet needs , Hematology Am Soc Hematol Educ Program : 2021,463-468
Ji, X, Jha A, Humenik J, Ghanem LR, Kromer A, Duncan-Lewis C, Traxler E, Weiss MJ, Barash Y, Liebhaber SA. RNA-binding proteins PCBP1 and PCBP2 are critical determinants of murine erythropoiesis. , Mol Cell Biol , 41(9): 2021,e0066820.
Halaby R, Cuker A, Yui J, Matthews A, Ishaaya E, Traxler E, Domenico C, Cooper T, Tierney A, Niami P, van der Rijst N, Adusumalli S, Gutsche J, Giri J, Pugliese S, Hecht THE, Pishko AM. Bleeding risk by intensity of anticoagulation in critically ill patients with COVID-19: a retrospective cohort study. , J Thromb Haemost , 19(6): 2021,1533-1545
Traxler EA, Thom CS, Yao Y, Paralkar V, Weiss MJ. Nonspecific inhibition of erythropoiesis by short hairpin RNAs. , Blood , 131(24): 2018,2733-2736
Traxler EA, Yao Y, Wang YD, Woodard KJ, Kurita R, Nakamura Y, Hughes JR, Hardison RC, Blobel GA, Li C, Weiss MJ. A genome-editing strategy to treat -hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition. , Nat Med , 22(9): 2016,987-90
Bui HM, Enis D, Robcuic MR, Nurmi HJ, Cohen J, Chen M, Yang Y, Dhillon V, Johnson K, Zhang H, Kirkpatrick R, Traxler E, Anisimov A, Alitalo K, Kahn ML. Anisimov A, Alitalo K, Kahn ML. Proteolytic activation defines distinct lymphangiogenic mechanisms for VEGFC and VEGFD. , J Clin Invest , 126(6): 2016,2167-80